Jianping Hu

1.3k total citations
87 papers, 1.0k citations indexed

About

Jianping Hu is a scholar working on Molecular Biology, Infectious Diseases and Materials Chemistry. According to data from OpenAlex, Jianping Hu has authored 87 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 15 papers in Infectious Diseases and 11 papers in Materials Chemistry. Recurrent topics in Jianping Hu's work include DNA and Nucleic Acid Chemistry (11 papers), HIV/AIDS drug development and treatment (11 papers) and RNA and protein synthesis mechanisms (8 papers). Jianping Hu is often cited by papers focused on DNA and Nucleic Acid Chemistry (11 papers), HIV/AIDS drug development and treatment (11 papers) and RNA and protein synthesis mechanisms (8 papers). Jianping Hu collaborates with scholars based in China, United States and India. Jianping Hu's co-authors include Shan Chang, Xu-hong Tian, Ming Liu, Xiaoqiang Guo, Ren Kong, Rui Xue, Guangbo Yang, Dianyong Tang, Xiaojun Gou and Hubing Shi and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Jianping Hu

81 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianping Hu China 19 615 144 140 99 95 87 1.0k
Wilian A. Cortopassi United States 16 537 0.9× 145 1.0× 100 0.7× 187 1.9× 81 0.9× 29 1.0k
Yaxue Zhao China 17 782 1.3× 70 0.5× 104 0.7× 161 1.6× 121 1.3× 44 1.2k
Ernesto R. Caffarena Brazil 18 445 0.7× 147 1.0× 123 0.9× 215 2.2× 43 0.5× 73 1.1k
Sayan Mondal United States 15 1.1k 1.7× 367 2.5× 96 0.7× 208 2.1× 112 1.2× 26 1.6k
R. Rajasekaran India 19 763 1.2× 124 0.9× 49 0.3× 197 2.0× 196 2.1× 112 1.4k
Li Du China 17 483 0.8× 59 0.4× 164 1.2× 113 1.1× 83 0.9× 33 968
Sebastian Bittrich United States 12 762 1.2× 131 0.9× 69 0.5× 85 0.9× 83 0.9× 23 1.1k
Andrew Krueger United States 6 736 1.2× 257 1.8× 47 0.3× 85 0.9× 124 1.3× 7 1.2k
Glenn F. Short United States 7 700 1.1× 218 1.5× 55 0.4× 100 1.0× 150 1.6× 9 1.1k
Rafael Andrade Caceres Brazil 17 593 1.0× 253 1.8× 156 1.1× 111 1.1× 136 1.4× 39 1.0k

Countries citing papers authored by Jianping Hu

Since Specialization
Citations

This map shows the geographic impact of Jianping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Hu more than expected).

Fields of papers citing papers by Jianping Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Hu. The network helps show where Jianping Hu may publish in the future.

Co-authorship network of co-authors of Jianping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianping Hu. A scholar is included among the top collaborators of Jianping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianping Hu. Jianping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jianping, et al.. (2025). LncNFYC-AS1 ameliorates Mycoplasma pneumoniae pneumonia via regulating miR-1323. BMC Pulmonary Medicine. 25(1). 457–457.
2.
Yang, Tiantian, et al.. (2025). Inhibitors of Type II NADH Dehydrogenase Enzyme: A Review. Current Protein and Peptide Science. 26(8). 593–608. 1 indexed citations
3.
Wu, Zhixiang, et al.. (2024). Revealing the graded activation mechanism of neurotensin receptor 1. International Journal of Biological Macromolecules. 278(Pt 1). 134488–134488. 2 indexed citations
4.
Yan, Cheng, et al.. (2024). Enhancing genome‐wide populus trait prediction through deep convolutional neural networks. The Plant Journal. 119(2). 735–745. 2 indexed citations
5.
Wang, Yong, Jianping Hu, Chen Chen, & Yongbo Li. (2024). PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc. Open Life Sciences. 19(1). 20220813–20220813. 2 indexed citations
6.
Liu, Ling, et al.. (2024). Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs: A WEB prediction approach. PLoS ONE. 19(12). e0303501–e0303501. 2 indexed citations
7.
Ward, Jennifer, Yvonne Sundström, Sarantos Kostidis, et al.. (2024). Phenomics‐Based Discovery of Novel Orthosteric Choline Kinase Inhibitors. Angewandte Chemie International Edition. 64(7). e202420149–e202420149.
8.
Zhang, Ruijia, Letian Yang, T. T. Lei, et al.. (2024). Discovery of a Potent, Orally Active, and Long-Lasting P2X7 Receptor Antagonist as a Preclinical Candidate for Delaying the Progression of Chronic Kidney Disease. Journal of Medicinal Chemistry. 67(19). 17472–17496. 2 indexed citations
9.
Hu, Jianping, et al.. (2023). Halogenation effects on the bridgehead position of the adamantane molecule. Chemical Physics Letters. 829. 140746–140746. 5 indexed citations
11.
Aravindhan, R., et al.. (2023). Solvatochromic shifts and solvent effects on the electronic and transport behaviour of 1-Chloro Adamantane. Physica Scripta. 99(1). 15013–15013. 1 indexed citations
12.
Ma, Xiaolong, et al.. (2021). Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p. Cell Death Discovery. 7(1). 309–309. 22 indexed citations
13.
Shi, Xiaodong, et al.. (2021). A promising strategy for increasing phosphorescent quantum yield: The ligand 10‐cyclic chelate of the tetradentate Pt(II) complex. Applied Organometallic Chemistry. 36(3). 3 indexed citations
14.
Chen, Zhong‐Zhu, et al.. (2019). Small substituent groups as geometric controllers for tridentate platinum(ii) complexes to effectively suppress non-radiative decay processes. Physical Chemistry Chemical Physics. 21(5). 2764–2770. 13 indexed citations
15.
Xie, Tao, Zhixiang Wu, Jinke Gu, et al.. (2019). The global motion affecting electron transfer in Plasmodium falciparum type II NADH dehydrogenases: a novel non-competitive mechanism for quinoline ketone derivative inhibitors. Physical Chemistry Chemical Physics. 21(33). 18105–18118. 9 indexed citations
16.
Hu, Jianping, Ying-Qing Wang, Yanlian Li, et al.. (2017). Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor. European Journal of Medicinal Chemistry. 137. 176–195. 30 indexed citations
17.
Liang, Li, et al.. (2016). [Molecular recognition mechanism and motion of HCV NS3/4A protease with Faldaprevir analogue].. Chinese journal of biotechnology/Shengwu gongcheng xuebao. 32(5). 669–682. 1 indexed citations
18.
Hu, Jianping, et al.. (2014). Molecular dynamics simulations of wild type and mutants of botulinum neurotoxin A complexed with synaptic vesicle protein 2C. Molecular BioSystems. 11(1). 223–231. 16 indexed citations
19.
Chang, Shan, et al.. (2012). Network models reveal stability and structural rearrangement of signal recognition particle. Journal of Biomolecular Structure and Dynamics. 30(2). 150–159. 2 indexed citations
20.
Chang, Shan, et al.. (2010). Substrate recognition and transport behavior analyses of amino acid antiporter with coarse-grained models. Molecular BioSystems. 6(12). 2430–2438. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026